AR084867A1 - Compuestos de acido [(5h-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-ht/agonistas inversos de actividad dual - Google Patents
Compuestos de acido [(5h-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-ht/agonistas inversos de actividad dualInfo
- Publication number
- AR084867A1 AR084867A1 ARP120100144A ARP120100144A AR084867A1 AR 084867 A1 AR084867 A1 AR 084867A1 AR P120100144 A ARP120100144 A AR P120100144A AR P120100144 A ARP120100144 A AR P120100144A AR 084867 A1 AR084867 A1 AR 084867A1
- Authority
- AR
- Argentina
- Prior art keywords
- benzodiazepin
- piperazin
- antagonists
- dimethylpropanoic
- pirrolo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 title abstract 2
- 230000009977 dual effect Effects 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000003420 antiserotonin agent Substances 0.000 title 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- BTWFSNJLQVPVHF-UHFFFAOYSA-N 2,2-dimethyl-3-[2-(11h-pyrrolo[2,1-c][1,4]benzodiazepin-6-yl)piperazin-1-yl]propanoic acid Chemical group OC(=O)C(C)(C)CN1CCNCC1C1=NC2=CC=CC=C2CN2C1=CC=C2 BTWFSNJLQVPVHF-UHFFFAOYSA-N 0.000 abstract 1
- 102100036321 5-hydroxytryptamine receptor 2A Human genes 0.000 abstract 1
- 101710138091 5-hydroxytryptamine receptor 2A Proteins 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos de ácido [(5H-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-HT2A/agonistas inversos de actividad dual y sus usos.Reivindicación 1: Un compuesto de la fórmula (1) caracterizado porque R1 es cloro o metilo; R2 es metilo, etilo, isopropilo, cloro, bromo, trifluorometilo, o metiltio; y R3 es hidrógeno o metoxi; o una sal del mismo farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161440092P | 2011-02-07 | 2011-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR084867A1 true AR084867A1 (es) | 2013-07-10 |
Family
ID=45558426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100144A AR084867A1 (es) | 2011-02-07 | 2012-01-16 | Compuestos de acido [(5h-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-ht/agonistas inversos de actividad dual |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8314092B2 (es) |
| EP (1) | EP2683719B1 (es) |
| JP (1) | JP5805215B2 (es) |
| KR (1) | KR101549315B1 (es) |
| CN (1) | CN103391940B (es) |
| AR (1) | AR084867A1 (es) |
| AU (1) | AU2012214788B2 (es) |
| BR (1) | BR112013019996A2 (es) |
| CA (1) | CA2826757C (es) |
| CY (1) | CY1116206T1 (es) |
| DK (1) | DK2683719T3 (es) |
| EA (1) | EA022708B1 (es) |
| ES (1) | ES2539502T3 (es) |
| HR (1) | HRP20150469T1 (es) |
| MX (1) | MX2013008786A (es) |
| PL (1) | PL2683719T3 (es) |
| PT (1) | PT2683719E (es) |
| RS (1) | RS54001B1 (es) |
| SI (1) | SI2683719T1 (es) |
| TW (1) | TWI564300B (es) |
| WO (1) | WO2012109011A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX341132B (es) * | 2011-07-08 | 2016-08-09 | Lilly Co Eli | Compuesto (tieno [2-3-b] [1,5] benzoxazepin-4-il) piperazin-1-ilo como agonista h1 inversos/antagonistas 5-ht2a de actividad doble. |
| CA2893106C (en) * | 2013-01-14 | 2017-07-18 | Eli Lilly And Company | (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
| CN114929688B (zh) * | 2019-10-21 | 2024-11-01 | 阿莱瑞恩公司 | 作为H1和5-HT2A-受体调节剂、用于治疗睡眠障碍的3-(4-(11H-二苯并[b,e][1,4]吖庚英-6-基)哌嗪-1-基)-和3-(4-(二苯并[b,f][1,4]氧杂吖庚英/硫杂吖庚英/二吖庚英-11-基)哌嗪-1-基)-丙酸衍生物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4192803A (en) * | 1978-09-15 | 1980-03-11 | American Cyanamid Company | 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives |
| US4507311A (en) * | 1981-12-07 | 1985-03-26 | Ciba-Geigy Corporation | Imidazo[1,2-c][1,3]benzodiazepines |
| US4460587A (en) | 1981-12-07 | 1984-07-17 | Ciba-Geigy Corporation | 5-Diazacycloalkyl imidazo[1,2-c][1,3]benzodiazepines |
| US4596799A (en) | 1985-01-29 | 1986-06-24 | Ciba-Geigy Corporation | 9H-pyrrolo[2,1-c]-1,2,4-triazolo[4,3-a][1,4]benzodiazepines |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| WO2006125812A1 (en) * | 2005-05-26 | 2006-11-30 | Janssen Pharmaceutica N.V. | Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
| GB0910009D0 (en) * | 2009-06-10 | 2009-07-22 | Glaxo Group Ltd | Novel compounds |
-
2012
- 2012-01-16 AR ARP120100144A patent/AR084867A1/es unknown
- 2012-01-20 TW TW101102371A patent/TWI564300B/zh not_active IP Right Cessation
- 2012-01-25 SI SI201230159T patent/SI2683719T1/sl unknown
- 2012-01-25 US US13/357,627 patent/US8314092B2/en active Active
- 2012-01-25 EA EA201390966A patent/EA022708B1/ru not_active IP Right Cessation
- 2012-01-25 JP JP2013552554A patent/JP5805215B2/ja active Active
- 2012-01-25 PL PL12701824T patent/PL2683719T3/pl unknown
- 2012-01-25 MX MX2013008786A patent/MX2013008786A/es active IP Right Grant
- 2012-01-25 BR BR112013019996A patent/BR112013019996A2/pt not_active Application Discontinuation
- 2012-01-25 AU AU2012214788A patent/AU2012214788B2/en not_active Ceased
- 2012-01-25 EP EP12701824.0A patent/EP2683719B1/en active Active
- 2012-01-25 PT PT127018240T patent/PT2683719E/pt unknown
- 2012-01-25 WO PCT/US2012/022455 patent/WO2012109011A1/en not_active Ceased
- 2012-01-25 HR HRP20150469TT patent/HRP20150469T1/hr unknown
- 2012-01-25 CN CN201280008068.3A patent/CN103391940B/zh active Active
- 2012-01-25 DK DK12701824T patent/DK2683719T3/en active
- 2012-01-25 CA CA2826757A patent/CA2826757C/en not_active Expired - Fee Related
- 2012-01-25 KR KR1020137020744A patent/KR101549315B1/ko not_active Expired - Fee Related
- 2012-01-25 ES ES12701824.0T patent/ES2539502T3/es active Active
- 2012-01-25 RS RS20150323A patent/RS54001B1/sr unknown
-
2015
- 2015-04-17 CY CY20151100361T patent/CY1116206T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1116206T1 (el) | 2017-02-08 |
| TWI564300B (zh) | 2017-01-01 |
| HRP20150469T1 (hr) | 2015-06-05 |
| CN103391940B (zh) | 2015-08-26 |
| PL2683719T3 (pl) | 2015-08-31 |
| ES2539502T3 (es) | 2015-07-01 |
| SI2683719T1 (sl) | 2015-05-29 |
| TW201245197A (en) | 2012-11-16 |
| EA022708B1 (ru) | 2016-02-29 |
| JP2014504637A (ja) | 2014-02-24 |
| EA201390966A1 (ru) | 2013-12-30 |
| RS54001B1 (sr) | 2015-10-30 |
| WO2012109011A1 (en) | 2012-08-16 |
| PT2683719E (pt) | 2015-06-05 |
| AU2012214788A1 (en) | 2013-07-11 |
| JP5805215B2 (ja) | 2015-11-04 |
| EP2683719B1 (en) | 2015-03-18 |
| MX2013008786A (es) | 2013-09-06 |
| AU2012214788B2 (en) | 2014-10-02 |
| KR20130103617A (ko) | 2013-09-23 |
| CN103391940A (zh) | 2013-11-13 |
| US20120202797A1 (en) | 2012-08-09 |
| EP2683719A1 (en) | 2014-01-15 |
| DK2683719T3 (en) | 2015-04-27 |
| KR101549315B1 (ko) | 2015-09-01 |
| US8314092B2 (en) | 2012-11-20 |
| BR112013019996A2 (pt) | 2018-07-24 |
| CA2826757C (en) | 2015-05-26 |
| CA2826757A1 (en) | 2012-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY33044A (es) | Derivados del acido carbamoil-metil-amino-acetico sustituido como inhibidores de nep novedosos | |
| PE20130382A1 (es) | Derivados de n-(imidazopirimidin-7-il)-heteroarilamida y su uso como inhibidores de pde10a | |
| ECSP12012292A (es) | Ciertas amino-piridazinas, composicioines de las mismas y métodos de uso de los mismos | |
| ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
| MX354021B (es) | Derivados de 5-fluor-4-imino-3- (sustituido) -3,4-dihidropirimidin -2 (1h) ona. | |
| ECSP12012293A (es) | Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos | |
| CR20120277A (es) | Una forma cristalina y amorfa de genz 112638 hemitartrato como inhibidores de glucosilceramida sintasa | |
| UY32660A (es) | Derivados aminobutricos sustituidos como inhibidores de neprilisina | |
| AR083870A1 (es) | Inhibidores de la replicacion del vih | |
| AR077014A1 (es) | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer | |
| GT201200164A (es) | "nuevos compuestos de espiropiperidina" | |
| UA107652C2 (en) | Carbazole compounds and therapeutic uses of the compounds | |
| EA201100612A1 (ru) | Новые производные 2-амидотиадиазола | |
| UY31883A (es) | Nuevo procedimiento de síntesis de 7,8-dimetoxi-1, 3-dihidro-2h-3-benzazepin-2-ona, y aplicación en la síntesis de ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
| AR092960A1 (es) | Procedimiento para preparar compuestos tienopirimidina | |
| EA201270099A1 (ru) | Транс-4-[[(5s)-5-[[[3,5-бис(трифторметил)фенил]метил](2-метил-2h-тетразол-5-ил)амино]-2,3,4,5-тетрагидро-7,9-диметил-1h-1-бензазепин-1-ил]метил]циклогексанкарбоновая кислота | |
| NZ707366A (en) | Novel histone deacetylase inhibitors and their use in therapy | |
| CL2010000253A1 (es) | Procedimiento de preparacion de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable; y uno de los compuestos intermediarios considerados. | |
| AR084867A1 (es) | Compuestos de acido [(5h-pirrolo[2,1-c][1,4]benzodiazepin-11-il)piperazin-1-il]-2,2-dimetilpropanoico sustituido como antagonistas de 5-ht/agonistas inversos de actividad dual | |
| PE20141789A1 (es) | Nuevos derivados de morofolinilo utiles como inhibidores de mogat-2 | |
| CO6361921A2 (es) | 3-aminociclopentancarboxamidas | |
| UY35036A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
| AR078486A1 (es) | Derivados de 3,5-diciano-4-(1h-indazol-5-il)-2,6-dimetil-1,4-dihidropiridina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades mediadas por receptores de quinasas c-met, en particular cancer y otros trastornos proliferativos. | |
| EA201391706A1 (ru) | Соединения (тиено[2,3-b][1,5]бензоксазепин-4-ил)пиперазин-1-ила в качестве соединений, обладающих двойной активностью обратных агонистов h1/антагонистов 5-ht | |
| UY35108A (es) | Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |